These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 7762498

  • 1. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2007 Jun 01; 7(5):1-101. PubMed ID: 23074505
    [Abstract] [Full Text] [Related]

  • 4. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.
    Lane DM, McConathy WJ, Laughlin LO, Comp PC, von Albertini B, Bricker LA, Kozlovskis P, Lees RS, Dorrier C.
    Atherosclerosis; 1995 Apr 24; 114(2):203-11. PubMed ID: 7605389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS.
    Clin Ther; 1995 Apr 24; 17(5):901-10. PubMed ID: 8595642
    [Abstract] [Full Text] [Related]

  • 11. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun 24; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA, van't Hof MA, Demacker PN, Stalenhoef AF.
    Atherosclerosis; 2000 Oct 24; 152(2):519-26. PubMed ID: 10998482
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ, Westerveld HT, Knipscheer HC, de Bruin TW, Kastelein JJ, Stalenhoef AF.
    Neth J Med; 1996 Aug 24; 49(2):59-67. PubMed ID: 8824106
    [Abstract] [Full Text] [Related]

  • 17. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Aug 24; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
    Nakandakare E, Garcia RC, Rocha JC, Sperotto G, Oliveira HC, Quintão EC.
    Atherosclerosis; 1990 Dec 24; 85(2-3):211-7. PubMed ID: 2102085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.